Hims & Hers Health has appointed Deb Autor as its first chief policy officer to lead public policy and government functions, ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Analysts also weigh in on Chesapeake Utilities, Halozyme Therapeutics, Sea Ltd., and Roper Technologies. Trump reverses on tariffs for some imports, Bitcoin falls on details of strategic reserve, ...

This expansion into diagnostics and tailored care represents a logical strategic extension of the company's telehealth model. Yet, the market's focus remained fixed on the worrying traffic and ...

Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite the consumer telehealth company launching a new ...

After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Shares of Mangoceuticals surged 28% ‌to $2.25 in premarket trading. U.S. regulations allow compounding pharmacies to copy ...

Global populations are aging, a reality that is leading to increased demand for healthcare services, chronic disease ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

The telehealth platform Hims & Hers delivered a jarring third-quarter earnings report that left investors reeling. While the ...

Companies don’t generally cut prices out of generosity.

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...